Novel therapeutic roles of MC-4 in combination with everolimus against advanced renal cell carcinoma by dual targeting of Akt/pyruvate kinase muscle isozyme M2 and mechanistic target of rapamycin complex 1 pathways-Reference-Cited by-同舟云学术

Novel therapeutic roles of MC-4 in combination with everolimus against advanced renal cell carcinoma by dual targeting of Akt/pyruvate kinase muscle isozyme M2 and mechanistic target of rapamycin complex 1 pathways

Published:2018-08-29 Issue:10 Volume:7 Page:5083-5095
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Son Ji Yeon¹,Yoon Sungpil¹,Tae In Hwan¹,Park Yu Jin¹,De Umasankar¹,Jeon Yukyoung¹,Park Young Ju¹,Rhyu Im Joo²,Lee Byung Mu¹,Chung Kyu-Huck¹,Lim Joung Eun³,Lee Se Jeong²,Lee Hye Won³⁴⁵^ORCID,Kwak Jong Hwan¹,Kim Hyung Sik¹,Choi Han Yong⁶

Affiliation:

1. School of Pharmacy; Sungkyunkwan University; Suwon Korea

2. Department of Anatomy; Korea University College of Medicine; Seoul Korea

3. Departments of Urology; Samsung Medical Center; Sungkyunkwan University School of Medicine; Seoul Korea

4. Department of Anatomy and Cell Biology; Sungkyunkwan University School of Medicine; Suwon Korea

5. Single Cell Network Research Center; Sungkyunkwan University School of Medicine; Suwon Korea

6. Department of Urology; Kangbuk Samsung Hospital; Seoul Korea

Funder

National Research Foundation of Korea

Ministry of Science, ICT and Future Planning

Publisher

Wiley